- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
AstraZeneca's revenue from top product Nexium 2006-2018
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
AstraZeneca's revenue from top product Nexium 2006-2018
AstraZeneca's revenue from top product Nexium from 2006 to 2018 (in million U.S. dollars)
This statistic shows AstraZeneca's revenue from the top product Nexium between 2006 and 2018. AstraZeneca plc is one of the top 10 pharmaceutical companies worldwide. The multinational company is headquartered in London, UK. AstraZeneca is focused on products for following major disease areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. In 2006, revenue from Nexium amounted to around 5.18 billion U.S. dollars.
AstraZeneca's revenue from top product Nexium from 2006 to 2018 (in million U.S. dollars)
| Revenue in million U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Revenue in million U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
© Statista 2019
About this statistic
Show source
Please be patient - this may take a moment
Description
Source
More information
- Show sources information
- Show publisher information
- Release date
- March 2019
- Region
- Worldwide
- Survey time period
- 2006 to 2018
- Supplementary notes
- Figures for 2006-2015 were taken from previous annual reports.
- Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- March 2019
More information
- Region
- Worldwide
- Survey time period
- 2006 to 2018
- Supplementary notes
- Figures for 2006-2015 were taken from previous annual reports.
- Open this statistic in...
Other statistics on the topic
Pharmaceutical Products & Market
Top pharmaceutical products by sales worldwide 2018
+Pharmaceutical Products & Market
AstraZeneca's top products based on revenue 2015-2018
+Pharmaceutical Products & Market
AstraZeneca's revenue from top product Crestor 2006-2018
+Cosmetics & Personal Care
Sales growth of leading antacid tablet brands in the U.S. 2018
You only have access to basic statistics.
This statistic is not included in your account!
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate solution including all features.
Prices do not include sales tax.
All Information
in one Presentation
- 38 page/s
- English
- pptx
- Detailed references
Everything On "Pharmaceutical brands: Crestor and Nexium (AstraZeneca)" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
- Overview
- Top 15 pharmaceutical products by sales worldwide in 2018 (in million U.S. dollars)Top pharmaceutical products by sales worldwide 2018
- Top products of AstraZeneca based on revenue from 2015 to 2018 (in million U.S. dollars)AstraZeneca's top products based on revenue 2015-2018
- AstraZeneca's revenue fom top product Crestor from 2006 to 2018 (in million U.S. dollars)AstraZeneca's revenue from top product Crestor 2006-2018
- Top generic drugs based on savings in the United States in 2018 (in million U.S. dollars)Total savings of top generic drugs in U.S. 2018
- AstraZeneca's revenue from top product Nexium from 2006 to 2018 (in million U.S. dollars)AstraZeneca's revenue from top product Nexium 2006-2018
- Sales growth of leading brands of antacid tablets in the United States in 2018 (change to prior sales year)Sales growth of leading antacid tablet brands in the U.S. 2018
- Dollar sales share of the leading antacid tablet brands in the United States in 2018*U.S. dollar sales share of the leading antacid tablet brands 2018
- Drug prices and consumer behavior
- Price disparities for top pharmaceutical product Nexium in the U.S. and abroad as of 2017 (in U.S. dollars per pill)*Price disparities for top product Nexium - U.S. and international 2017
- Esomeprazole out-of-pocket cost in the U.S. from 2004 to 2016 (in U.S. dollars)*Esomeprazole out of pocket cost U.S. 2004-2016
- Price disparities for pharmaceutical product Crestor in the U.S. and abroad as of 2017 (in U.S. dollars per pill)*Price disparities for top product Crestor - U.S. and international 2017
- Rosuvastatin calcium out-of-pocket cost in the U.S. from 2004 to 2016 (in U.S. dollars)*Rosuvastatin calcium out-of-pocket cost U.S. 2004-2016
- Advertising expenditures
- AstraZeneca advertising spending in the United States from 2012 to 2018 (in million U.S. dollars)AstraZeneca: ad spend in the U.S. 2012-2018
- Leading pharmaceutical companies in the United States in 2017, by direct to consumer spending (in million U.S. dollars)Leading pharmaceutical companies in the U.S. 2017, by DTC
- Leading pharmaceutical companies in the United States between January and august 2019, by professional health print journals ad spend (in million U.S. dollars)Pharma companies with largest print ad spend in the U.S. 2019
- AstraZeneca's R&D expenditure as a percentage of revenue 2006-2018
- AstraZeneca's revenue from top product Seroquel 2006-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2018
- Average prices of Nexium - selected countries 2013
- AstraZeneca's expenditure on research and development 2006-2018
- AstraZeneca - number of animals used for research purposes 2006-2018
- AstraZeneca's employees by region 2018
- AstraZeneca's operating profit 2006-2018
- AstraZeneca's revenue by therapeutic area 2015-2018
- AstraZeneca - ad spend in the U.S. 2014, by medium
- AstraZeneca's revenue 2013-2018 by region
- Sectors with largest jobs impacts on the U.S. biopharma industry 2014
- U.S. biopharmaceutics: employment by occupation
- Usage rate of top drug classes prescribed to seniors in Canada 2016, by location
- U.S. consumer feelings about direct-to-consumer pharmaceutical ads in 2017
- Inadequate health insurance in the U.S.
- Slovakia: number of pharmaceutical preparations manufacturers 2008-2016
- Structure of the North American cosmeceuticals market by country 2015
- Natural language processing market revenue worldwide by segment 2017-2025
- Nobel Prize Laureates in physics by nationality up to 2018
- Sobi Anual and sustainability report 2017
- Pharmaceutical industry in Italy
- Pharmaceutical trends in Europe
- Biotechnology in Germany
- PAGB Annual Review 2017-2018
- Teva - 2018 Form 10-K
- Indicatori Farmaceutici
- Novo Nordisk ANNUAL REPORT 2017
- Generic Pharmaceutical Industry Yearbook 2016
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans, 2006 to 2013
- Top pharmaceutical products by sales worldwide 2018
- AstraZeneca's top products based on revenue 2015-2018
- AstraZeneca's revenue from top product Crestor 2006-2018
- Total savings of top generic drugs in U.S. 2018
- AstraZeneca's revenue from top product Nexium 2006-2018
- Sales growth of leading antacid tablet brands in the U.S. 2018
- U.S. dollar sales share of the leading antacid tablet brands 2018
- Price disparities for top product Nexium - U.S. and international 2017
- Esomeprazole out of pocket cost U.S. 2004-2016
- Price disparities for top product Crestor - U.S. and international 2017
- Rosuvastatin calcium out-of-pocket cost U.S. 2004-2016
- AstraZeneca: ad spend in the U.S. 2012-2018
- Leading pharmaceutical companies in the U.S. 2017, by DTC
- Pharma companies with largest print ad spend in the U.S. 2019
- AstraZeneca's R&D expenditure as a percentage of revenue 2006-2018
- AstraZeneca's revenue from top product Seroquel 2006-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2018
- Average prices of Nexium - selected countries 2013
- AstraZeneca's expenditure on research and development 2006-2018
- AstraZeneca - number of animals used for research purposes 2006-2018
- AstraZeneca's employees by region 2018
- AstraZeneca's operating profit 2006-2018
- AstraZeneca's revenue by therapeutic area 2015-2018
- AstraZeneca - ad spend in the U.S. 2014, by medium
- AstraZeneca's revenue 2013-2018 by region
- Sectors with largest jobs impacts on the U.S. biopharma industry 2014
- U.S. biopharmaceutics: employment by occupation
- Usage rate of top drug classes prescribed to seniors in Canada 2016, by location
- U.S. consumer feelings about direct-to-consumer pharmaceutical ads in 2017
- Inadequate health insurance in the U.S.
- Slovakia: number of pharmaceutical preparations manufacturers 2008-2016
- Structure of the North American cosmeceuticals market by country 2015
- Natural language processing market revenue worldwide by segment 2017-2025
- Nobel Prize Laureates in physics by nationality up to 2018
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
- Demographics
- Economy
- Education & Science
- Politics & Government
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
As a Premium user you get access to the detailed source references and background information about this statistic.
As a Premium user you get access to background information and details about the release of this statistic.
As soon as this statistic is updated, you will immediately be notified via e-mail.
You need at least a Premium Account to use this feature.
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.